AI-focused medical company Renovaro has announced a new partnership with Nebul to harness its AI cloud infrastructure for advanced research. Renovaro will leverage Nebul’s high-performance computing (HPC) platform to support deep learning and machine learning efforts aimed at revolutionizing early cancer detection.
David Weinstein, CEO of Renovaro, emphasized the critical importance of this collaboration, stating: “By tapping into Nebul’s specialized data centers, we can significantly accelerate the development of a next-generation diagnostic test for lung cancer. Our goal is to create an ultra-sensitive test capable of detecting minimal residual disease (MRD), a key factor in preventing relapse and improving long-term patient outcomes.”
Weinstein further noted that Renovaro’s deep learning models demand immense computing power, robust security, and seamless scalability all of which Nebul is equipped to provide. With its dedicated data centers, private AI cloud services, and emphasis on privacy and expert support, Nebul is positioned as a strategic ally for advancing AI solutions in clinical settings.
Nebul, a European AI cloud provider headquartered in Leiden, South Holland, was established in 2022. The company offers cutting-edge Nvidia platforms, including DGX, HGX, OVX, and RTX, powered by top-tier GPUs like B200, H200, H100, L40s, and L4. In mid-2024, Nebul secured €20 million ($22.7 million) in funding to further expand its operations. While specific details about its data centers remain limited, Nebul highlights the use of energy-efficient green facilities strategically located across Europe.
For more tech updates, visit DC Brief.
